Mylan’s too-harsh takeover defense

Steven Davidoff Solomon writes for The New York Times, May 8, 2015

It was not unexpected that Mylan would react negatively to Teva’s approach. Neither company has ever gotten along particularly well. But in terms of a negative response, Mylan’s is an 11 on a scale of one to 10.